Clark David Michael's Form 4 filing
Amicus Therapeutics, Inc. (FOLD) · filed Jan 4, 2023
- Accession no.
- 0001209191-23-001404
- Filed
- Jan 4, 2023
- Trade date
- Jan 2-3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $102.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Clark David MichaelCIK 0001755662 | Officer (Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2023 | Common Stock | FTax withholdingDisposed | −11,336 | $12.21 | −$138,412.56 | 198,696 | Direct | |
| Jan 3, 2023 | Common Stock | SSaleDisposed | −8,493 | $12.03F2 | −$102,170.79 | 190,203 | Direct | |
| Jan 3, 2023 | Common Stock | AGrant or awardAcquired | +59,372 | $0.00 | $0 | 249,575 | Direct | |
| Jan 3, 2023 | Common Stock | FTax withholdingDisposed | −5,810 | $11.93 | −$69,313.3 | 243,765 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Common Stock | AGrant or awardAcquired | +105,388 | $0.00 | $0 | 105,388 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.82 to $12.24. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.